Volume 15, Number 11—November 2009
Research
Imported Infectious Diseases in Mobile Populations, Spain
Table 2
Syndrome | Total population, no. (%), N = 2,198 | Sub-Saharan Africans, no. (%), n = 1,564 | Latin Americans, no. (%), n = 634 | p value | |
---|---|---|---|---|---|
Hematologic–eosinophilia | 570 (26) | 435 (28) | 135 (21.3) | 0.002 | |
Dermatologic | 544 (24.7) | 477 (30.5) | 67 (10.6) | 0.001 | |
Fever | 451 (20.5) | 351 (22.4) | 100 (15.8) | 0.001 | |
Asymptomatic | 396 (18) | 268 (17.1) | 128 (20.2) | 0.09 | |
Gastrointestinal | 363 (16.5) | 269 (17.2) | 94 (14.8) | 0.608 | |
Respiratory | 314 (14.3) | 209 (13.4) | 105 (16.6) | 0.006 | |
Hematologic–anemia | 283 (12.9) | 230 (14.7) | 53 (8.4) | 0.001 | |
Genitourinary | 234 (10.6) | 198 (12.7) | 36 (5.7) | 0.001 | |
Neurologic | 219 (10) | 144 (9.2) | 75 (11.8) | 0.03 | |
Musculoskeletal | 169 (7.7) | 141 (9) | 28 (4.4) | 0.001 |
*Because each patient could have >1 main reason for seeking medical assistance, the number of cases can be higher than the number of patients. Percentages were calculated as number of cases divided by number of patients in each group (total population, sub-Sahara African immigrants, or Latin American immigrants).
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.